Comparative Analysis of All-Cause Health Care Resource Utilization and Costs Among Venous Thrombosis Patients Without Cancer Prescribed Apixaban or VKAs in France.
Ruth MokgokongArtak KhachatryanNadia QuignotJose ChavesAudrey MoniotGaelle GustoPublished in: Advances in therapy (2022)
Compared to VKAs, apixaban may be cost-saving in the treatment of patients hospitalized for acute VTE.